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Abstract
Background: Spain has one of the lowest rates of breast cancer in Europe, though estimated incidence has risen substantially
in recent decades. Some years ago, the Spanish Cancer Mortality Atlas showed Spain as having a heterogeneous distribution of
breast cancer mortality at a provincial level. This paper describes the municipal distribution of breast cancer mortality in Spain
and its relationship with socio-economic indicators.
Methods: Breast cancer mortality was modelled using the Besag-York-Molliè autoregressive spatial model, including socio-
economic level, rurality and percentage of population over 64 years of age as surrogates of reproductive and lifestyle risk factors.
Municipal relative risks (RRs) were independently estimated for women aged under 50 years and for those aged 50 years and
over. Maps were plotted depicting smoothed RR estimates and the distribution of the posterior probability of RR>1.
Results: In women aged 50 years and over, mortality increased with socio-economic level, and was lower in rural areas and
municipalities with higher proportion of old persons. Among women aged under 50 years, rurality was the only statistically
significant explanatory variable.
For women older than 49 years, the highest relative risks were mainly registered for municipalities located in the Canary Islands,
Balearic Islands, the Mediterranean coast of Catalonia and Valencia, plus others around the Ebro River. In premenopausal
women, the pattern was similar but tended to be more homogeneous. In mainland Spain, a group of municipalities with high RRs
were located in Andalusia, near the left bank of the Guadalquivir River.
Conclusion: As previously observed in other contexts, mortality rates are positively related with socio-economic status and
negatively associated with rurality and the presence of a higher proportion of people over age 64 years. Taken together, these
variables represent the influence of lifestyle factors which have determined the increase in breast cancer frequency over recent
decades. The results for the younger group of women suggest an attenuation of the socio-economic gradient in breast cancer
mortality in Spain. The geographical variation essentially suggests the influence of other environmental variables, yet the
descriptive nature of this study does not allow for the main determinants to be established.
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Background
Breast cancer is the leading malignant tumour in women,
accounting for 27% of cancers in European women [1].
Spain has one of the lowest rates in Europe, in terms both
of incidence (estimated age-standardised rate of 51 per
100,000 population) more especially, of mortality (16 per
100,000)[1]. The major risk factors seem to be genetic sus-
ceptibility, reproductive behaviour, obesity and, less con-
sistently demonstrated, diet[2]. Ecological studies have
shown an association with fertility, body weight or fat
consumption, but these variables explained only a minor
component of the overall variation[3]. A positive associa-
tion between breast cancer and socio-economic level has
been consistently reported [4-10]. Although socio-eco-
nomic status can be a surrogate of several risk factors
(reproductive behaviour, diet or physical activity) [11-
13], these variables do not completely explain the excess
risk observed in the more affluent groups[8].
One of the classic approaches in epidemiology is the study
of geographical distribution. In administrative terms,
Spain is divided into Autonomous Regions known as
Comunidades Autónomas. These are in turn divided into
provinces and, at the lowest level, into municipalities.
Breast cancer mortality has been previously studied at a
provincial level. The highest standardised rates observed
in Las Palmas Province (Canary Islands) were double
those registered for Orense, the province with the lowest
rate[14].
Currently, spatial epidemiology allows for a greater level
of disaggregation. One of the advantages of this approach
is to highlight local effects that might be linked to specific
geographic, social or environmental characteristics[15].
This study reports on municipal distribution of breast can-
cer mortality in Spain and the variability associated with
socio-economic level and other explanatory variables.
Furthermore, given that pre- and postmenopausal
tumours have somewhat different risk factors (i.e. obesity
seems to act as protective exposure in younger women and
is a well-established risk factor among postmenopausal
women), the geographical pattern is independently
explored in women aged under 50 years or 50 years and
over.
Methods
As our case source, we used all Spanish individual death
entries for the period 1989–1998 corresponding to breast
cancer (International Classification of Diseases, 9th Revi-
sion (ICD-9) code 174) broken down by municipality. A
municipality is an administrative unit, made up of a
clearly demarcated territory and its population, governed
by a municipal council. This is the smallest aggregated
division for which mortality and population data could
be obtained at a national basis for the study period. Mor-
tality data were furnished by the National Statistics Insti-
tute. Municipal populations, broken down by age group
(18 groups) and sex, were obtained from the 1991 census
and 1996 municipal rolls. These years correspond to the
midpoints of the two quinquennia that comprise the
study period (1989–1993 and 1994–1998). The person-
years for each five-year period were obtained by multiply-
ing these populations by 5.
As an indicator of socio-economic level, the index pro-
vided by the Spanish Credit Bank (Banco Español de
Crédito) for 1991 was used[16]. This index classifies
municipalities into 10 levels, according to different mark-
ers of economic activity, namely, the number of holiday
homes, bank branch offices and telephones, and esti-
mated average family income. An indicator of rurality was
drawn up, based on the number of inhabitants, as classi-
fied by the National Statistics Institute in the following 10
categories: > 500,000; 100,001–500,000; 50,001–
100,000; 20,001–50,000; 10,001–20,000; 5,001–10,000;
2,001–5,000; 1,001–2,000; 501–1,000; and 101–500 and
<100 inhabitants. Finally, the percentage of people over
the age of 64 years living in each municipality was
deemed to be a surrogate of life-style factors that might
have changed and were less prevalent in older genera-
tions.
Standardised mortality ratios (SMRs) were computed as
the ratio of observed to expected deaths. Expected cases
were computed, taking Spanish breast cancer mortality
rates, broken down by age and five-year period, as refer-
ence. SMRs were also calculated by province and category
of explanatory variable, and confidence intervals for these
categories were duly computed using Byar's approach[17].
Breast cancer mortality was separately studied among
women aged under 50 years and comprised deaths from
cancers diagnosed mainly in premenopausal women and
among women aged 50 years and over. This latter group
was made up of a mixture of pre- and postmenopausal
cases but was nevertheless dominated by the second
group.
Smoothed municipal relative risks (RRs) were calculated
using the conditional autoregressive model introduced by
Clayton and Kaldor[18], and further developed by Besag,
York and Molliè [19]. This model has been applied in the
field of ecological studies[20]. It is a Poisson spatial
model with observed cases as the dependent variable,
expected cases as offset, and two random effects terms that
take the following into account: a) municipal contiguity
(spatial term); and b) municipal heterogeneity. Socio-eco-
nomic level, rurality and percentage of people over the age
of 64 years were introduced into the model as continuous
explanatory variables. The purpose was twofold: 1) toBMC Cancer 2007, 7:78 http://www.biomedcentral.com/1471-2407/7/78
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ascertain their influence on breast cancer mortality; and 2)
to smooth relative risk, taking into account the variability
associated with these factors rather than merely the spatial
relationship among municipal areas. The model took the
following form
where: λi is the relative risk in area I; Oi is the number of
deaths in area I; Ei are the expected cases; βj is the coeffi-
cient representing the effect (log(RR)) of the explanatory
variable J, xji refers to the value of the explanatory variable
J in the area I, hi is the municipal heterogeneity term; and
bi is the spatial term.
Models were fitted using Bayesian Markov Chain Monte
Carlo simulation methods[21]. Posterior distributions of
RR were obtained using WinBugs[22]. The criterion of
contiguity used was adjacency. Convergence was verified
using the BOA (Bayesian Output Analysis) R programme
library[23]. Given the great number of parameters, the
convergence analysis was performed on a randomly
selected sample of 10 towns and cities, taking 4 strata
defined by municipal size. Convergence of the estimators
was achieved before 100,000 iterations. Risk estimators
were computed after a "burn-in" (iterations discarded to
ensure convergence) of 300,000 iterations, based on the
posterior distribution observed in the next 5,000 itera-
tions.
For comparison purposes, standard Poisson regression
models were also fitted, with the three explanatory varia-
bles being included to quantify their effect on mortality.
Confidence intervals were computed using robust esti-
mates of variance[24], as a way of taking overdispersion
into account.
A Geographic Information System was used to plot
municipal maps that depicted smoothed RR and the dis-
tribution of the posterior probability (pp) that RR>1
(Bayesian equivalent to p value). Insofar as this indicator
was concerned, we followed Richardson's criterion[15],
which recommends that probabilities above 0.8 should
be deemed significant.
Results
From 1989 to 1998, a total of 56711 breast cancer deaths
were registered. Eighty-four percent (47789) corre-
sponded to women aged over 49 years, and the remaining
8922 to younger women. In 3328 municipalities there
were no deaths due to this cause. Ninety percent of these
villages had less than 1000 inhabitants and the number of
expected cases in all of these was lower than 1. Further-
more, 3% of the Spanish population lived in municipali-
ties that registered no breast cancer deaths during the
study period. Table 1 displays a number of descriptive sta-
tistics, including the distribution of population and
explanatory variables, as well as observed and expected
cases of breast cancer in the two age groups considered.
To give an overall picture, Figure 1 shows breast cancer
mortality by province. There were only two provinces with
SMRs greater than 1.20, namely, Las Palmas in the Canary
Islands (SMR = 1.42), and the Balearic Islands (SMR =
1.21). Jaén in Andalusia registered the lowest mortality
(SMR = 0.67). SMRs ranging from 0.70 to 0.80 were
observed in Cuenca and Guadalajara (Castile-La Man-
cha), Lugo and Orense (Galicia), Granada (Andalusia)
and Avila (Castile-León).
Breast cancer mortality in women 50 and more years old:
Figure 2 depicts the relationship between breast cancer
mortality in these women and the three explanatory vari-
ables. Breast cancer mortality increased with socio-eco-
nomic level, though a sharp drop is observed in the
highest income category. For the other two variables,
rurality and percentage of subjects aged over 64 years, a
downward trend was observed. Table 2 lists the RR for
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Table 1: Summaries of population, other explanatory variables and breast cancer mortality in 8077 Spanish towns. Spain, 1989–1998.
Total Mean Standard Deviation Median Min Max P5 – P95 No. (%) with zero counts
Population 39648759 4908.9 42430.4 586 5 2866850 63 – 14177 0 (0)
Socioeconomic index - 5.23 2.17 5 1 10 1 – 9 0 (0)
% Population >=65 - 23.4 9.58 22.3 0 100 10.4 – 40.8 0 (0)
Women >=50
Observed breast cancer cases 47789 5.9 65.8 1 0 4283 0 – 16 3522 (43.6)
Expected number 47789 5.9 60.9 1.0 0.003 4274.5 0.3 – 16.1 0 (0)
SMR 1.00 0.84 2.27 0.53 0 5.85 0.00 – 2.79 3522 (43.6)
Women <50
Observed breast cancer cases 8922 1.1 11.2 0 0 718 0 – 4 6237 (77.2)
Expected number 8922 1.1 10.5 0.1 0 704.3 0.0 – 3.2 36 (0.5)
SMR 1.00 0.98 6.17 0.0 0 333.3 0.00 – 3.52 6237 (77.2)BMC Cancer 2007, 7:78 http://www.biomedcentral.com/1471-2407/7/78
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these explanatory variables, using conventional Poisson
regression (left) and the Bayesian model (right). Results in
both models were quite similar. Given the trends
observed in Figure 2, natural splines were used to investi-
gate possible non-linear trends associated with these vari-
ables, but the goodness-of-fit failed to improve.
Figure 3 shows the smoothed RR map for this age-group
(top), together with the distribution of posterior probabil-
ities of having a relative risk greater than 1 (bottom). The
highest mortality was registered for the Canary Islands
and, to a lesser extent, for the Balearic Islands. On the
Spanish mainland, increased mortality was observed
along the east coast, chiefly in the Autonomous Regions of
Catalonia and Valencia. In Catalonia, RRs were signifi-
cantly higher than 1 for the four provincial capitals, in the
area around Barcelona and on the coast from Tarragona to
Torroella de Montgrí. Most municipalities around the
Ebro River, downstream from Calahorra onwards, as well
as around the Ebro's tributaries, the Cinca and the Segre,
are highlighted on the map, and many have posterior
probabilities greater than 0.8. In the Autonomous Region
Provincial distribution of breast cancer mortality in women: Spain, 1989–1998 Figure 1
Provincial distribution of breast cancer mortality in women: Spain, 1989–1998.
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of Valencia, excess risks were concentrated along the coast,
particularly in Valencia Province. Almost all provincial
capitals in northern and eastern Spain registered excess
risk, with posterior probabilities greater than 0.9. Finally,
some municipalities in Madrid, Extremadura and Andalu-
sia also presented statistically significant, high RRs.
Municipalities with RRs greater than 1.25, based on a dif-
ference between observed and expected numbers equal to
or greater than 3 cases and with a posterior probability
equal to or greater than 0.9 are shown in Table 3. Relative
Table 2: Effect of explanatory variables on breast cancer mortality in women over 49 years of age.
Variable Conventional Poisson regression model Bayesian model (Besag-York-Molliè)
RR 95% Confidence Interval RR 95% Credibility Interval
Socio-economic index
per 1 unit 1.069 1.053–1.086 1.046 1.033–1.059
Rurality
Change per category1 0.988 0.975–1.000 0.979 0.972–0.986
% Population >=65
Change per 10% 0.988 0.984–0.993 0.992 0.992–0.995
1 Categories: 0 = > 500.000 inhabitants, 1 = 100.001–500.000, 2 = 50.001–100.000, 3 = 20.001–50.000, 4 = 10.001–20.000, 5 = 5.001–10.000, 6 = 
2.001–5.000, 7 = 1.001–2.000, 8 = 501–1.000, 9 = 101–500, 10 = <100 inhabitants.
Relationship between breast cancer mortality in women aged 50 years and over (SMRs), and the following three explanatory  variables: socio-economic index; rurality; and percentage of subjects over 64 years of age Figure 2
Relationship between breast cancer mortality in women aged 50 years and over (SMRs), and the following three explanatory 
variables: socio-economic index; rurality; and percentage of subjects over 64 years of age.
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risks of over 1.50 were only seen in the Canary Islands.
Explanatory variables did not fully account for the excess
risk observed in all these municipalities, since their RR
were substantially higher than the value obtained by only
taking the linear predictor into account, i.e., the part of the
model that includes the three explanatory variables.
Breast cancer mortality in women younger than 50 years:
Observed deaths among premenopausal women
accounted for only 16% of overall breast cancer mortality,
and 6237 municipalities registered zero cases (Table 1).
While no clear trend was associated with socio-economic
level or percentage of population above the age of 64,
SMRs were inversely associated with rurality (data not
shown). This information is summarised by RR estimators
of these factors (Table 4). As rurality was the only statisti-
cally significant variable, the final model only included
this explanatory term. The geographical pattern (Figure 4)
was less marked than in older women, with a somewhat
greater risk in Canary Islands, Balearic Islands, the city of
Valencia and south-west Andalusia (Cadiz and Seville). In
this last-mentioned area, there was a cluster of municipal-
ities with higher risk, located near the left bank of the
Guadalquivir River, including towns and cities such as
Jerez de la Frontera, El Puerto de Santa María, Puerto Real
and Chiclana in Cadiz, and Utrera, Seville, Alcalá de
Guadaira and Dos Hermanas in Seville. Table 5 shows
those municipalities with RRs equal to or greater than
1.10, a posterior probability of over 0.80 and a difference
between observed and expected cases equal to or greater
than 3.
Discussion
Our results reflect excess breast cancer mortality in
women aged over 49 years in the Canary Islands, Balearic
Islands, Catalonia and Valencia. Furthermore, high signif-
icant excess risks were observed in municipalities of La
Rioja, Navarre, Aragon and Catalonia around the Ebro
River. Most provincial capitals in the north and east of
Spain displayed increased RR. Lastly, Badajoz, Mérida and
Almendralejo in Extremadura, Seville and Alcalá de
Guadaira in the Province of Seville, and Puerto Real and
Puerto de Santa María in Cadiz registered high, significant
RRs. The geographical pattern in younger women
appeared to be more uniform and no RR over 1.20 were
in evidence. The only exception was Tuineje (Las Palmas).
On the Spanish mainland, a group of municipalities with
high RRs were located in two Andalusian provinces, Cadiz
and Seville, near the Guadalquivir River.
When seeking possible etiological clues, it could be
argued that incidence would be more valuable than mor-
tality, given that in Spain breast cancer survival rates are
quite high, i.e., around 78% at five years[25]. Neverthe-
less, mortality is the only global source of information
available in this country. Breast cancer is a well-certified
cause of death in Spain, with both detection and confir-
mation rates exceeding 90%[26]. Incidence rates would
not be useful for comparison purposes during the study
period, since Spanish Autonomous Regions put their
screening programmes in place during the 1990s. Screen-
ing artificially increases incidence, by advancing diagnosis
of very small tumours and including cases that will not
progress[27]. In view of regional differences in the starting
point of screening programmes around Spain, extracting
conclusions based on incidence would be problematic in
this particular period. Mortality rates, on the other hand,
are not influenced by such overdiagnosis. Although it
would be interesting to study the influence of screening
programmes on breast cancer mortality, the time-frame
renders this impossible because, in almost all cases, the
first round of screening was only completed after 1995 in
the territories in question.
Municipal RRs were estimated, including three ecological
variables in the model, namely: the socio-economic index
provided by the Spanish Credit Bank; the number of
inhabitants categorised by the National Statistics Institute;
and the percentage of subjects aged over 64 years. These
variables were used as markers of the heterogeneous dis-
tribution of lifestyle and reproductive factors influencing
breast cancer frequency. Selection of these variables was
limited by the availability of information at a municipal
level, so they only partially reflect the distribution of
breast cancer risk factors in Spain. However, their inclu-
sion served to smooth relative risks, taking into account
both the spatial relation among municipalities and the
variability associated with these indices. In the model pro-
posed by Besag, York and Molliè, modelling the clustering
variation allows for unmeasured risk factors that vary
smoothly with location. Where the pattern of covariate
variation is similar to that of disease risk, location may act
as a confounder[20]. This phenomenon will produce a
change in the regression coefficient on introduction of the
spatial clustering term. In our study, this location-induced
confounding effect is small, as can be seen by comparing
the estimated effects yielded by Besag, York and Molliè
models against those yielded by conventional Poisson
regression (see Tables 2 and 4).
Small area analysis tends to reduce ecological fallacy,
since the populations defined by municipal boundaries
are more homogeneous. This might well be true of villages
and towns of average size. In large cities, however, the
results reported here correspond to an overall mean, and
socio-economic and mortality differences inside cities
have been disregarded. It could be very interesting to
assess whether such differences exist in major Spanish cit-
ies, such as Madrid, Barcelona, Valencia, Seville andBMC Cancer 2007, 7:78 http://www.biomedcentral.com/1471-2407/7/78
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Municipal distribution of breast cancer mortality in women aged 50 years and over: Spain, 1980–1999 Figure 3
Municipal distribution of breast cancer mortality in women aged 50 years and over: Spain, 1980–1999. Distribution pattern of 
smoothed relative risk (RR) under the BYM model (top) and posterior probability of RR being greater than 1 (bottom).
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Zaragoza. This internal variability could not been
explored in this paper.
Risk factors for breast cancer may differ for premenopau-
sal and postmenopausal cancers [2]. Family history and
hereditary susceptibility are particularly relevant for pre-
menopausal tumours [28,29], whereas obesity and repro-
ductive behaviour are generally more important in
postmenopausal women. The geographical pattern of pre-
menopausal breast cancer was designated as a specific
goal of the study. One third of breast cancer diagnoses in
Spain occur in premenopausal women [30] and breast
cancer mortality before age 50 may be considered as due
to premenopausal cancers [31]. The geographical distribu-
Table 3: Breast cancer mortality in women over 49 years of age in Spain. Towns (grouped by province) having a difference between 
the number of observed and expected cases equal to or greater than 3, an RR of over 1.25 and a posterior probability (pp) of over 0.9. 
Spain,1989–1998.
CCAA
Province Municipality RR pp SMR obs exp Rurality SE %Pop >65
ANDALUSIA
Cadiz PUERTO DE SANTA MARIA 1.27 0.994 1.49 76 50.94 2 6 7.74
Sevilla SAN JUAN DE AZNALFARACHE 1.31 0.992 1.84 39 21.24 3 6 10.17
ARAGON
Zaragoza UTEBO 1.26 0.907 1.77 12 6.78 5 7 9.37
BALEARIC ISLANDS
Mallorca CALVIA 1.47 0.998 1.42 22 15.50 3 9 7.02
Mallorca PALMA DE MALLORCA 1.41 1.000 1.43 502 350.25 1 8 13.27
Mallorca ANDRAITX 1.32 0.938 1.32 13 9.88 5 9 15.91
Menorca CIUTADELLA DE MENORCA 1.32 0.941 1.39 30 21.56 3 6 12.16
Ibiza EIVISSA 1.28 0.961 1.45 37 25.44 3 8 9.09
Mallorca ESPORLES 1.28 0.960 2.06 9 4.37 6 8 18.18
Mallorca FELANITX 1.27 0.983 1.52 31 20.44 4 8 19.03
CATALONIA
Barcelona VILAFRANCA DEL PENEDES 1.33 0.996 1.43 49 34.35 3 8 13.79
GIRONELLA 1.32 0.945 1.95 17 8.73 5 7 22.00
VILANOVA I LA GELTRU 1.32 0.997 1.40 79 56.39 3 7 13.76
CABRILS 1.30 0.976 2.06 7 3.41 6 9 10.49
BARBERA DEL VALLES 1.29 0.987 1.64 33 20.09 3 7 6.93
CABRERA DE MAR 1.28 0.961 2.08 6 2.88 6 9 10.03
VILASSAR DE MAR 1.27 0.975 1.45 20 13.83 4 8 11.93
S. MARGARIDA I ELS MONJOS 1.26 0.974 1.79 7 3.90 6 8 11.69
SANT PERE DE RIBES 1.25 0.961 1.30 18 13.82 4 7 10.14
Gerona BEGUR 1.46 0.986 2.25 7 3.11 6 9 11.52
TORROELLA DE MONTGRI 1.40 0.993 1.63 14 8.58 5 9 14.27
PALAMOS 1.38 0.992 1.48 25 16.91 5 9 13.01
PALAFRUGELL 1.33 0.987 1.23 26 21.16 4 8 14.46
PUIGCERDA 1.32 0.942 1.39 11 7.90 5 8 14.63
CALONGE 1.31 0.983 1.78 12 6.73 5 9 14.67
Lerida SOLSONA 1.31 0.930 1.53 13 8.52 5 8 16.24
TARREGA 1.26 0.987 1.72 27 15.74 4 7 18.24
Tarragona CALAFELL 1.38 0.989 1.63 15 9.22 4 8 14.1
COMUNIDAD VALENCIANA
Alicante SANTA POLA 1.36 0.962 1.59 25 15.71 4 6 10.79
Valencia BENIPARRELL 1.34 0.959 4.30 6 1.40 7 10 11.77
CANARY ISLANDS
Las Palmas ARUCAS 1.63 1.000 1.90 49 25.75 3 5 9.97
TELDE 1.63 1.000 1.70 91 53.40 2 5 6.82
PALMAS DE GRAN CANARIA 1.58 1.000 1.56 516 330.42 1 6 9.4
SANTA BRIGIDA 1.58 1.000 1.83 22 11.99 4 6 9.58
INGENIO 1.52 0.999 1.50 24 16.01 3 5 6.81
SAN BARTOLOME DE TIRAJANA 1.49 1.000 1.42 23 16.16 3 6 5.57
FIRGAS 1.47 0.999 1.71 10 5.84 5 5 10.53
TEROR 1.43 0.999 1.32 15 11.33 4 5 11.68
VALSEQUILLO DE GRAN CANARIA 1.43 0.999 2.04 11 5.40 5 5 9.79
MOYA 1.41 0.998 1.96 17 8.68 5 5 12.25
SANTA LUCIA 1.39 0.992 1.24 25 20.15 3 5 5.83
GALDAR 1.37 0.992 1.39 26 18.64 3 5 9.47
Tenerife SAN SEBASTIAN DE LA GOMERA 1.52 0.939 2.27 12 5.28 5 6 10.17
ARONA 1.38 0.985 1.67 25 14.93 3 7 6.12
BASQUE COUNTRY
Guipuzcoa HONDARRIBIA 1.26 0.957 1.68 25 14.85 4 7 11.53
CCAA = Autonomous Community. RR = estimated relative risk. SMR = standard mortality ratio. pp = posterior probability that RR>1. SE = socio-economic index.BMC Cancer 2007, 7:78 http://www.biomedcentral.com/1471-2407/7/78
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tion observed for the younger group, albeit attenuated,
was no different to that observed for older women. The
most distinctive result was the higher risk registered in
south-west Andalusia, near the course of the Guadalquivir
River.
Research indicates that use of well-chosen census tract
socio-economic measures can provide important insights
into socio-economic disparities in the burden of breast
cancer[32]. In our study, using the economic classification
provided by the Spanish Credit Bank, a positive gradient
of mortality was observed. Although socio-economic class
is a poorly understood concept that has not been homo-
geneously measured[7], a positive association between
this factor and breast cancer has consistently been
reported [4-7,9,10]. Socio-economic status can be related
to environmental exposures and reproductive behaviours
(e.g., nulliparity)[7,11]. In terms of mortality, however,
greater survival, coupled with higher participation in
screening programmes[32], have been observed in more
affluent groups[7]. In Europe, the ELDCARE study has
shown a strong correlation between breast cancer survival
and national gross domestic product (correlation coeffi-
cient of 0.80) [33]. Spanish survival rates are greater than
those expected from this correlation, probably reflecting
lower inequalities in access to adequate medical serv-
ices[33]. Yet women living in most affluent municipalities
might receive earlier diagnosis and treatment, and this
would explain the comparatively lower SMR observed for
the highest socio-economic category (see Figure 2).
Socio-economic level was not associated with breast can-
cer mortality in younger women. This result is in agree-
ment with the few studies available that looked into
changes in social inequalities in breast cancer mortal-
ity[31,34,35]. Social disparities are decreasing more
quickly in younger groups[31]. One explanation could be
better prognosis in young women from affluent areas, due
to their greater awareness and access to medical diagnosis,
since these age groups are not included in mass screening
programmes. Alternatively, the lack of socio-economic
differences in younger women may reflect a more uniform
pattern vis-à-vis lifestyle factors. Thus, parity has
decreased in France more markedly among women with
lower educational levels[31]. Likewise, in Finland the
decline in educational differences in breast cancer mortal-
ity has been associated with changes in reproductive
behaviour and body mass index among less educated
women[35].
In our study, breast cancer mortality in both age groups
was higher in more urban areas, which is consistent with
the increased incidence observed in urban settings[8].
Lower incidence in rural areas probably reflects differ-
ences in education, age at first birth and other breast-can-
cer-related factors. On the other hand, when considering
mortality, real differences in incidence may be attenuated,
since lower participation rates in screening programmes
have been reported in rural areas[32] and this translates as
a lower number of in situ tumours and a higher propor-
tion of more advanced stages with increased lethality[36].
Rurality was the only explaining factor negatively associ-
ated with mortality in women under the age of 50 years,
probably indicating that changes in lifestyle risk factors
occurred earlier in urban areas.
A negative correlation was observed between the percent-
age of old population and breast cancer mortality in
women aged 50 years or over. Birth-cohort trends reflect
demographic patterns that are related to recognised breast
cancer risk factors[37]. Age-cohort-period analysis of
breast cancer mortality across time has consistently shown
a strong variation associated with the cohort component,
in Europe [38] and in Spain[39]. An analysis performed
among carriers of BRCA1 and BRCA2 mutations, showed
a greater incidence of breast cancer in younger birth-
Table 4: Effect of the explanatory variables on breast cancer mortality in women younger than 50.
Variable Conventional Poisson regression model Bayesian model (Besag-York-Molliè)
Three factor model RR 95% Confidence Interval RR 95% Credibility Interval
Socio-economic index
per 1 unit 1.002 0.974–1.029 0.992 0.967–1.016
Rurality
Change per category1 0.978 0.965–0.992 0.978 0.965–0.991
% Population >=65
Change per 10% 1.004 0.998–1.011 1.004 0.998–1.011
Final model
Rurality
Change per category1 0.981 0.968–0.993 0.982 0.977–0.993
1 Categories: 0 = > 500.000 inhabitants, 1 = 100.001–500.000, 2 = 50.001–100.000, 3 = 20.001–50.000, 4 = 10.001–20.000, 5 = 5.001–10.000, 6 = 
2.001–5.000, 7 = 1.001–2.000, 8 = 501–1.000, 9 = 101–500, 10 = <100 inhabitants.BMC Cancer 2007, 7:78 http://www.biomedcentral.com/1471-2407/7/78
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cohorts compared with relatives of these women belong-
ing to older generations[40]. This indicates that, even
among mutation carriers, lifestyle factors more prevalent
in younger cohorts determine the overall risk. Lifestyle
changes have been remarkable in Spain. During the first
half of the 1990s, Spain had the lowest birth rate in
Europe[41]. Furthermore, the decline in fertility proved
particularly sharp in Spain, where the mean birth rate
dropped from 2.86 in 1970 to 1.18 in 1995[41]. The rea-
sons for this rapid decrease were: improved quality of life
and education; increased contraceptive use; and the sheer
speed of social change nationwide[41]. There has also
been a massive influx of women into the workforce and,
due to high unemployment, children now tend to live
longer in the parental home than in the past[41]. In terms
of dietary patterns, there is evidence to show that rapid
urbanisation and the growing proportion of females in
the active workforce have led to important changes in
food patterns in recent decades, with an increase in con-
sumption of animal products, such as meat, fish, milk and
dairy products, fats and processed foods. In contrast, there
has been a decrease in consumption of cereals, potatoes
and legumes[42,43]. These changes can be assumed to be
linked to younger generations. Given the length of the
study period, an age-cohort-period analysis was not advis-
able. The percentage of population aged over 64 years was
chosen to reflect the presence of older generations, which
could be deemed both an indicator of the relative weight
of elder cohorts in these municipalities, and a marker of
the social and cultural environment, on the assumption
that such an environment would modulate the speed of
change. It is possible, however, that part of the observed
association between breast cancer mortality and the pro-
portion of people aged over 64 years living in any given
area may be somewhat spurious, resulting from the com-
parison of SMRs across regions with different age struc-
tures. If this were the case, the inclusion of this variable in
the model would enable smoothed RRs to be obtained,
taking this distribution into account.
Although the three explanatory variables are interrelated,
all were retained in the final model for older women,
showing that, to a certain extent, they act as surrogates for
different risk factors. Nevertheless, RRs for municipalities
with high breast cancer mortality seemed to be higher
than the predicted trend that had been estimated accord-
ing to these variables. This implies the intervention of
other conditions not properly captured by these ecologi-
cal variables. Postmenopausal women with high body
mass index have an increased risk[2]. Fourteen percent of
Spanish women are obese and a further 28% are over-
weight[44]. Obesity is more prevalent in Andalusia, Extre-
Table 5: Breast cancer mortality in women under 50 years of age in Spain. Towns (grouped by province) having a difference between 
the number of observed and expected cases equal to or greater than 3, an RR greater than 1.10 and a posterior probability (pp) of over 
0.8. Spain, 1989–1998.
CCAA
Province Municipality RR pp SMR Obs Exp Rurality
ANDALUSIA
Cadiz CHICLANA DE LA FRONTERA 1.16 0.928 1.90 19 9.99 3
JEREZ DE LA FRONTERA 1.13 0.967 1.27 52 40.78 1
EL PUERTO DE SANTA MARIA 1.14 0.912 1.33 21 15.76 2
PUERTO REAL 1.13 0.907 1.60 11 6.86 3
ROTA 1.11 0.805 1.63 8 4.91 3
SAN FERNANDO 1.16 0.925 1.37 26 19.03 2
Sevilla ALCALA DE GUADAIRA 1.12 0.932 1.40 17 12.12 2
LOS PALACIOS Y VILLAFRANCA 1.11 0.848 1.50 9 6.01 3
SEVILLA 1.15 0.995 1.16 186 160.87 0
UTRERA 1.11 0.919 1.90 17 8.94 3
BALEARIC ISLANDS
Mallorca MANACOR 1.13 0.803 1.50 9 6.02 3
CATALONIA
Barcelona BARCELONA 1.18 1.000 1.25 487 389.01 0
TERRASSA 1.10 0.920 1.30 49 37.62 1
CANARY ISLANDS
Las Palmas LAS PALMAS DE GRAN CANARIA 1.15 0.942 1.10 91 82.99 1
TELDE 1.15 0.895 1.21 21 17.43 2
TUINEJE 1.62 0.919 3.63 5 1.38 5
COMUNIDAD VALENCIANA
Valencia VALENCIA 1.14 0.994 1.19 219 183.79 0
CCAA = Autonomous Community. RR = estimated relative risk. SMR = standard mortality ratio. pp = posterior probability that RR>1.BMC Cancer 2007, 7:78 http://www.biomedcentral.com/1471-2407/7/78
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Municipal distribution of breast cancer mortality in women under 50 years of age: Spain, 1980–1999 Figure 4
Municipal distribution of breast cancer mortality in women under 50 years of age: Spain, 1980–1999. Distribution pattern of 
smoothed relative risk (RR) under the BYM model (top) and posterior probability of RR being greater than 1 (bottom).
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madura, Castile-La Mancha and the Canary Islands[44].
Yet, obesity would not seem to explain the observed geo-
graphical pattern. Insofar as nutrition is concerned, over
the past 100 years, the mean age of menarche has declined
from 16 to 14 years in all industrialised nations[45,46].
This phenomenon has been predominantly attributed to
abundant nutrition during childhood[47]. In this regard,
the higher risk in the Balearic and Canary Islands can be
partly linked to the higher proportion of European immi-
grants who come from countries with higher incidence of
breast cancer and now live in these regions. These women
have spent their childhood in areas with higher back-
ground rates.
At an individual level, well-established breast-cancer risk
factors account for less than 50% of overall incidence[48].
Like most chronic diseases, breast cancer is considered to
be the result of an interaction between genetic and envi-
ronmental factors[29,49]. Hereditary susceptibility plays
an important role in breast cancer pathogenesis, but time-
trends as well as twin-studies suggest that in sporadic
breast cancer, environmental, nutritional and lifestyle fac-
tors dominate over genetic predisposition[47,49]. Envi-
ronmental factors are believed to account for a large
proportion of cases. Apart from ionising radiation, a well-
established risk factor, some chemicals induce mammary
cancer in rodents, though evidence in humans is lack-
ing[50]. For instance, to show that in rats, cadmium at
very low doses acts as an oestrogen mimic, indicating a
need to investigate the effects of metals on breast cancer
risk[51]. Pesticides are also of interest because many
mimic oestrogen or cause mammary tumours in ani-
mals[52,53]. The most abundant of these contaminants
are the pesticide, dichloro-diphenyl-trichloroethane
(DDT), and polychlorinated biphenyls (PCBs)[50]. They
are included among persistent organic compounds, given
that they degrade slowly, bioaccumulate and may be
found in human adipose tissue, blood and breast milk.
The most prevalent organic compound residues found in
human tissues are dichlorodiphenyldichloroethane
(DDE) -the major metabolite of DDT- and PCBs. Availa-
ble epidemiological evidence linking pesticides and breast
cancer is considered inadequate[50]. A recent meta-analy-
sis concluded that, taken together, available results pro-
vide enough evidence to discard a relationship between
breast cancer and DDT[54], and organochlorine exposure
is not believed to be causally related to breast cancer[55].
Nevertheless, these studies provide no information on
exposure during critical periods of human development,
namely, from conception to adolescence[54]. In Spain,
even though DDT was banned in 1977, a recent study
showed that 99% of the 682 samples collected from
healthy people in the Canary Islands displayed detectable
levels of some DDT-derivatives[56]. The presence of a very
high DDT/DDE ratio indicated chronic exposure to DDT,
which has persisted until now[56]. The highest levels were
seen in Gran Canaria, the island on which the municipal-
ities with the highest RR are located. However, given the
current state of knowledge, any implication of DDT and
DDE levels in the excess mortality observed in Gran
Canaria is highly speculative.
High breast cancer mortality was also observed along the
Ebro river in postmenopausal women and near the left
bank of the Guadalquivir River in premenopausal
women. Both rivers are included among fluvial areas with
chemical pollution in Spain[57]. The Ebro river has
received a great amount of pollutants, including pesti-
cides, hydrocarbons and nitrates[57]. A recent study
shows that organochlorine contaminants continue to be
of concern in this area and that, among its degradation
products, DDT still predominates, indicating recent
inputs of this banned substance[58].
Conclusion
Even though breast cancer mortality has begun to decline
in Spain, a heterogeneous geographical pattern is in evi-
dence, with higher rates in the Canary Islands, the Balearic
Islands, the Mediterranean coast of Catalonia and Valen-
cia, and a series of municipalities around the Ebro River.
Among premenopausal women, increased mortality was
also observed for municipalities located along the last
third of the Guadalquivir River. As has been previously
reported in other contexts, mortality rates are positively
associated with socio-economic status and negatively
associated with rurality and the presence of a higher pro-
portion of persons over the age of 64 years (born before
1931). Taken together, these variables represent the influ-
ence of lifestyle factors that have determined the increase
in breast cancer frequency over recent decades. On the
other hand, the results for the younger group of women
would suggest an attenuation of the socio-economic gra-
dient in breast cancer mortality. The geographical varia-
tion mainly suggests the influence of other environmental
variables, though a heterogeneous distribution of genetic
factors cannot be ruled out. The descriptive nature of this
study means, however, that the main determinants of this
pattern cannot be ascertained.
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